Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–10 of 10 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
NCT06545942
- Conditions
- Adnexal Diseases, Advanced Solid Tumor, Breast Cancer, +36 more
- Locations
-
- Investigative Site #108 Goodyear, Arizona, United States
- Investigative Site #101 La Jolla, California, United States
- Investigative Site #111 San Francisco, California, United States
- Investigative Site #104 Lake Mary, Florida, United States
NCT03522064
- Conditions
- Castration-resistant Prostate Cancer, Homologous Recombination Deficiency
- Locations
-
- Kinghorn Cancer Centre, St. Vincent's Hospital Sydney, New South Wales, Australia
NCT06095141
- Conditions
- Homologous Recombination Deficiency, Pancreatic Adenocarcinoma
- Locations
-
- Shanghai Cancer Center Shanghai, China
NCT04515836
- Conditions
- Adenoma, Homologous Recombination Deficiency, Lung Diseases, +12 more
- Locations
-
- University of Chicago Medical Center Chicago, Illinois, United States
NCT04503265
- Conditions
- Adnexal Diseases, Advanced Malignant Neoplasm, Breast Cancer, +35 more
- Locations
-
- University of California, Los Angles (UCLA) Department of Medicine - Hematology/Oncology Los Angeles, California, United States
- Johns Hopkins Baltimore, Maryland, United States
- SCRI Oncology Partners Nashville, Tennessee, United States
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT06525298
- Conditions
- Advanced Solid Tumor, HRR Deficiency, Homologous Recombination Deficiency
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Lorigerlimab (MGD019) in Patients With Pancreatic Adenocarcinoma and Homologous Recombination Deficiency
NCT07565155
- Conditions
- Homologous Recombination Deficiency, Pancreatic Adenocarcinoma
- Locations
-
- University of Miami Miami, Florida, United States
Basket Trial of IDX-1197, a PARP Inhibitor, in Patients With HRR Mutated Solid Tumors (VASTUS)
NCT04174716
- Conditions
- Homologous Recombination Deficiency, Homologous Recombination Repair Gene Mutation, Solid Tumors
- Locations
-
- National Cancer Centre Goyang, Gyeongggi-do, South Korea
- Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea
- Ajou University Hospital Suwon, Gyeonggi-do, South Korea
- Gyeongsang National University Hospital Jinju, Gyeongsangnam-do, South Korea
A Study on Association Between HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer
NCT04651920
- Conditions
- Adnexal Diseases, BRCA1 Mutation, BRCA2 Mutation, +23 more
- Locations
-
- Lei Li Beijing, Beijing Municipality, China
The HER Project: HRD in EGFR-mutated NSCLC
NCT07303218
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- Dept. Medical Oncology Milan, MI, Italy